The program is still filling in: the organizers list three tracks as under development and many talk titles as to be confirmed. We’ll add new sessions and the organizations presenting them as the agenda grows.

Vaccine supply, safety and access at World Vaccine Congress 2027

Mar 8–11, 2027 Washington, DC ~3k attendees Website

34 organizations at World Vaccine Congress 2027 present work in supply, safety & access: 15 public-health and non-profit bodies, 9 academic bodies, 7 suppliers and service providers and 3 vaccine and drug developers. Between them they bring 37 presentations to the program. Most represented: Pfizer, Boston Children's Hospital and University of Pennsylvania. As of Oct 8, 2026.

All 222 organizations at World Vaccine Congress 2027 →

Showing 1–17 of 34 organizations

Organization	World Vaccine Congress 2027 Attendance
Pfizer New York, NY
pfizer.com Large pharma Global pharmaceutical company with a vaccine portfolio spanning pneumococcal, RSV, COVID-19 and other infectious diseases.	Keynote Tue Mar 9 14:55 The Longevity Dividend: Scaling Adult Immunization for an Aging Global Population How vaccines for older adults can overcome age-related immune decline and a crowded adult schedule, and how to raise low uptake worldwide. with Africa CDC Clinical & preclinical developmentSupply, safety & access Talk Wed Mar 10 15:10 Pfizer Respiratory Vaccine Pipeline Updates Influenza & Respiratory Diseases Track Talk Wed Mar 10 16:40 Strategies for large scale vaccinations for the world – multidose vial and CMC challenges Bioprocessing & Manufacturing Track
Boston Children's Hospital Boston, MA
childrenshospital.org Academic Pediatric teaching hospital of Harvard Medical School, home to the Precision Vaccines Program.	Talk Mon Mar 8 10:00 Vaccine Technology Workshop New vaccine technologies, from machine learning that pairs adjuvants with antigens to self-amplifying RNA and a liposome-adjuvanted malaria vaccine. with Montani Biotechnologies, Arcturus Therapeutics, Akagera Medicines +2 more Talk Wed Mar 10 09:10 Vaccine Safety Track: sessions to be announced with Johns Hopkins Bloomberg School of Public Health, Brighton Collaboration, Global Vaccine Data Network +1 more Talk Thu Mar 11 09:10 The Vanguard of Preparedness: Using Humanized In Vitro Systems to Predict Neonatal and Pediatric Immunogenicity for Outbreak Pathogens Pandemic Platforms Track
University of Pennsylvania Philadelphia, PA
upenn.edu Academic Research university whose Perelman School of Medicine pioneered the modified mRNA used in COVID-19 vaccines.	Talk Mon Mar 8 10:00 AMR Workshop How vaccines, antibodies and phage therapy can be developed, funded and used against drug-resistant bacteria, from infant infections to livestock. with Omniose, AMR Strategic Coalition, Gates Foundation +6 more Talk Wed Mar 10 12:30 The Exemption Expansion: Mandate Trends Under Trump II Vaccine Access Track Talk Thu Mar 11 09:40 Protective Pan-Betacoronavirus Neutralizing Antibodies by Vaccination Pandemic Platforms Track
Moderna Cambridge, MA
modernatx.com Large pharma mRNA medicines company with marketed vaccines against COVID-19 and RSV, and mRNA candidates for influenza, other infections and cancer.	Chair Wed Mar 10 09:00 Chair’s opening remarks Vaccine Safety Track
Callen-Lorde New York, NY
callen-lorde.org Academic Community health center providing primary care and sexual health services to LGBTQ communities in New York City.	Talk Mon Mar 8 10:00 HIV Vaccines Workshop Where the search for an HIV vaccine stands, from laboratory advances and ongoing clinical trials to plans for fair global access. with Fred Hutch, IAVI, ModeX Therapeutics Keynote Thu Mar 11 14:20 Closing Keynote: Reimagining public health infrastructure in the USA – opportunities to rebuild with intention How the US could rebuild its public health system for the long term, from disease forecasting and biodefense to universal vaccine access. with Infectious Diseases Society of America, Manatt Health Supply, safety & access
Americas Health Foundation Washington, DC
americashealthfoundation.org Public health & non-profit Nonprofit that convenes experts to produce evidence and policy recommendations to widen healthcare access in Latin America.	Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. with London School of Hygiene & Tropical Medicine, Think Vaccines, Gavi, the Vaccine Alliance +2 more Supply, safety & accessInfectious disease & AMR
Baylor College of Medicine Houston, TX
bcm.edu Academic Medical school whose Texas Children's Hospital Center for Vaccine Development develops low-cost vaccines for neglected and emerging diseases.	Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. with London School of Hygiene & Tropical Medicine, Think Vaccines, Gavi, the Vaccine Alliance +2 more Supply, safety & accessInfectious disease & AMR
Gavi, the Vaccine Alliance Geneva, Switzerland
gavi.org Public health & non-profit Global vaccine alliance funding immunization and shaping vaccine markets for lower-income countries.	Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. with London School of Hygiene & Tropical Medicine, Think Vaccines, Americas Health Foundation +2 more Supply, safety & accessInfectious disease & AMR
Georgetown University Washington, DC
georgetown.edu Academic Private research university in Washington, DC, with schools of medicine, nursing, law and health policy.	Talk Wed Mar 10 09:10 Vaccine Safety Track: sessions to be announced with Boston Children's Hospital, Johns Hopkins Bloomberg School of Public Health, Brighton Collaboration +1 more
Global Vaccine Data Network Auckland, New Zealand
globalvaccinedatanetwork.org Academic International research network pooling health data across countries to study vaccine safety and effectiveness.	Talk Wed Mar 10 09:10 Vaccine Safety Track: sessions to be announced with Boston Children's Hospital, Johns Hopkins Bloomberg School of Public Health, Brighton Collaboration +1 more
Manatt Health
manatt.com Consulting & services Health policy and strategy consulting practice of the law firm Manatt, Phelps & Phillips.	Keynote Thu Mar 11 14:20 Closing Keynote: Reimagining public health infrastructure in the USA – opportunities to rebuild with intention How the US could rebuild its public health system for the long term, from disease forecasting and biodefense to universal vaccine access. with Callen-Lorde, Infectious Diseases Society of America Supply, safety & access
Merck Rahway, NJ
merck.com Large pharma Global pharmaceutical company (MSD outside the US and Canada) making vaccines against pneumococcal disease, HPV, measles and other infections.	Chair Wed Mar 10 09:00 Chair’s opening remarks Vaccine Supply & Logistics Track
Unimed Leicester, United Kingdom
unimedps.com Consulting & services Global health procurement firm handling sourcing, quality assurance, logistics and technical assistance for governments, aid agencies and NGOs, with a U.S. arm.	Talk Wed Mar 10 09:10 Vaccine Supply & Logistics Track: sessions to be announced
University of Western Australia Perth, Australia
uwa.edu.au Academic Public research university in Perth, Western Australia.	Talk Wed Mar 10 12:10 MandEval Program - A mixed methods and multi-country study of the implementation and impact of COVID-19 vaccine mandates Vaccine Access Track
Vaccinate Your Family Washington, DC
vaccinateyourfamily.org Public health & non-profit Non-profit advocating for on-time vaccination for people of all ages in the US.	Talk Wed Mar 10 14:40 Navigating the US Vaccine Policy Landscape 2027 Current US vaccine policy questions, including measles elimination status, compensation for COVID-19 vaccine injuries and legal liability for vaccine makers.
Vaccine Formulation Institute
vaccineformulationinstitute.org Public health & non-profit Swiss centre of expertise in adjuvants and vaccine formulation that develops adjuvants and supplies them at GMP grade under open-access terms.	Talk Mon Mar 8 10:00 Global Health Workshop How to move vaccines for poorer countries past long-standing roadblocks in development, and what shapes fair access in low-resource settings. with London School of Hygiene & Tropical Medicine, Think Vaccines, Gavi, the Vaccine Alliance +2 more Supply, safety & accessInfectious disease & AMR
Africa CDC Addis Ababa, Ethiopia
africacdc.org Public health & non-profit Africa Centres for Disease Control and Prevention, the African Union's public health agency for disease surveillance, outbreak response and immunization.	Keynote Tue Mar 9 09:30 Keynote Panel: Are We Ready for the Next Outbreak? Reconciling Surveillance, Diagnostics, and the MCM Pipeline How surveillance, diagnostics and regulators can work together to get vaccines deployed quickly in sudden outbreaks of viruses like Ebola and Marburg. with ACEGID, PATH, International Vaccine Institute Infectious disease & AMR Keynote Tue Mar 9 14:55 The Longevity Dividend: Scaling Adult Immunization for an Aging Global Population How vaccines for older adults can overcome age-related immune decline and a crowded adult schedule, and how to raise low uptake worldwide. with Pfizer Clinical & preclinical developmentSupply, safety & access